Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study

被引:20
|
作者
Ghosh, Sanjib Kumar [1 ,2 ]
Raheja, Shashi [1 ,2 ]
Tuli, Anita [1 ,2 ]
Raghunandan, Chitra [3 ]
Agarwal, Sneh [1 ,2 ]
机构
[1] Lady Hardinge Med Coll & Hosp, Dept Anat, New Delhi 110001, India
[2] Smt Sucheta Kriplani Hosp, New Delhi 110001, India
[3] Lady Hardinge Med Coll & Hosp, Dept Obstet & Gynecol, New Delhi 110001, India
关键词
Uterine artery Doppler velocimetry (UADV); Placental growth factor (PIGF); Pre-eclampsia; Odds ratio; Logistic regression analysis; CIRCULATING ANGIOGENIC FACTORS; BLOOD-FLOW PATTERN; WAVE-FORMS; HYPERTENSIVE DISORDERS; ULTRASOUND; RISK; WOMEN; EXPRESSION; 2ND-TRIMESTER; GESTATION;
D O I
10.1016/j.ejogrb.2011.12.031
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the effectiveness of the combined use of uterine artery Doppler velocimetry (UADV) and estimation of maternal serum placental growth factor (PIGF) levels in early second trimester (20-22 weeks of gestation) in identifying pregnant women at risk of developing pre-eclampsia. Study design: Prospective cohort study on 1104 pregnant women with singleton pregnancies between May 2009 and December 2010. UADV and maternal serum PIGF estimation were done at 20-22 weeks' gestation. Association between the two variables and the occurrence of pre-eclampsia was analyzed by logistic regression analysis and odds ratio was computed. The results were considered significant when p was <0.05. Results: Logistic regression analysis showed that both abnormal UADV (odds ratio (OR) 4.1; 95% CI 2.3-7.2; p = 0.000) and serum PIGF < 188 pg/ml (OR 3.6; 95% CI 1.95-6.5; p = 0.000) are independent variables in the occurrence of pre-eclampsia, and the difference between the association of these two variables with pre-eclampsia was statistically insignificant as 95% Cl values overlap. Multivariate logistic regression analysis showed that a combination of abnormal UADV and serum PIGF < 188 pg/ml at 20-22 weeks had a very poor association (OR 1.1; 95% CI 0.3-3.8; p = 0.938) with the occurrence of pre-eclampsia, as the 95% Cl values encompass 1 and p is >0.05. Conclusion: UADV and maternal serum PIGF estimation at 20-22 weeks of gestation are strong predictors of the occurrence of pre-eclampsia when used individually but in combination their association with pre-eclampsia is not significant. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:144 / 151
页数:8
相关论文
共 47 条
  • [31] THE POTENTIAL ROLE OF FIRST TRIMESTER MATERNAL SERUM PP13 AND SECOND-TRIMESTER UTERINE ARTERY DOPPLER PULSATILITY INDEX AS MARKERS OF PRE-ECLAMPSIA AMONG HIGH RISK EGYPTIAN PREGNANT FEMALES
    Mehaney, D.
    Shehata, M.
    Elsherbini, M.
    Elkomy, R.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2013, 9 (03) : 429 - 438
  • [32] Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers
    Litwinska, Ewelina
    Litwinska, Magdalena
    Oszukowski, Przemyslaw
    Szaflik, Krzysztof
    Kaczmarek, Piotr
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (03): : 439 - 448
  • [33] Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population
    Kienast, Carolin
    Moya, Walter
    Rodriguez, Oswaldo
    Jijon, Alfredo
    Geipel, Annegret
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (04): : 537 - 543
  • [34] Placental biophysical model for prediction of early onset fetal growth restriction in first and second trimester of pregnancy: A prospective cohort study
    Kumar, Manisha
    Balyan, Kirti
    Debnath, Ekta
    Humtsoe, Ben
    Meena, Bhawana
    Ravi, V.
    Singh, Shalini
    PLACENTA, 2024, 154 : 153 - 159
  • [35] Correlation of Placental Growth Factor with Pre-Eclampsia during Mid Trimester of Pregnancy: A Case Control Study at Liaquat University of Medical and Health Sciences, Pakistan
    Memon, Khalid Yousuf
    Ujjan, Ikram Din
    Yousuf, Nailla
    Ala, Syed Hasan
    Rustamani, Shabnam
    Shaikh, Fozia
    Chang, Abid Hussain
    Mahrukh, Suha
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (11) : EC42 - EC44
  • [36] Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia
    Andrietti, S.
    Carlucci, S.
    Wright, A.
    Wright, D.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 50 (02) : 221 - +
  • [37] A prospective observational cohort study to evaluate a novel point-of-care placental growth factor test for pre-eclampsia prediction in Sierra Leone
    Kuhrt, Katy
    M'Bayoh, Moses
    Bramham, Kate
    Shennan, Andrew
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 132 : 74 - 74
  • [38] Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia - a case-control study
    Law, Lai Wa
    Sahota, Daljit Singh
    Chan, Lin Wai
    Chen, Min
    Lau, Tze Kin
    Leung, Tak Yeung
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2011, 24 (06): : 808 - 811
  • [39] Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia
    Lai, Jonathan
    Pinas, Ana
    Poon, Leona C. Y.
    Agathokleous, Maria
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2013, 33 (03) : 164 - 172
  • [40] The role of second trimester uterine artery Doppler in predicting obstetric and neonatal outcomes in abnormal first trimester maternal serum pregnancy-associated plasma protein-A and free β-human chorionic gonadotropin values
    Dal, Yusuf
    Akkus, Fatih
    Karagun, Sebnem
    Nessar, Ahmet Zeki
    Karaca, Sefanur Gamze
    Coskun, Ayhan
    JOURNAL OF CLINICAL ULTRASOUND, 2024, 52 (04) : 394 - 404